Back to search
FDAFDA · Food and drugs·Recall number D-1534-2016

Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection, Vital Care Compounder, Hattiesburg, MS 39402

Published October 5, 2016 · Recall initiated: July 26, 2016

Summary

FDA records drug Class II recall D-1534-2016, published October 5, 2016 and initiated July 26, 2016. Recalling firm: Pharmacy Plus, Inc. dba Vital Care Compounder; Status: Terminated; Reported quantity: 3 vials; Lot: Lot# 386184, Use by 08-03-16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmacy Plus, Inc. dba Vital Care Compounder
Distributor
MS
Lot
Lot# 386184, Use by 08-03-16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Papaverine 150 mg / Phentolamine 5 mg vials, packaged 5.5 mL in a sterile, clear 10 mL MDV, Rx only, Sterile Injection, Vital Care Compounder, Hattiesburg, MS 39402 recalled?

Yes. FDA published recall D-1534-2016 on October 5, 2016. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone